Author Question: The _______________ phase begins when the patient enters the operating room suite and ends with ... (Read 85 times)

jasdeep_brar

  • Hero Member
  • *****
  • Posts: 569
The _______________ phase begins when the patient enters the operating room suite and ends with admission to the postanesthesia care unit (PACU).
 
  Fill in the blanks with correct word

Question 2

Which assistive device would most benefit a patient with a neuromuscular weakness?
 
  a. Large-print labels
  b. A syringe with a magnifier
  c. Screw-top medication containers
  d. Color-coded tops for medications



meganlapinski

  • Sr. Member
  • ****
  • Posts: 333
Answer to Question 1

intraoperative
The intraoperative phase begins when the patient enters the operating room suite and ends with admission to the PACU.

Answer to Question 2

C
For patients with a weakened grasp or pain in the hands and fingers, have the local pharmacist place medications in a screw-top container. Larger labels and syringe magnifiers are used for patients with visual alterations. Color-coding systems are designed for patients taking multiple medications.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

The National Institutes of Health have supported research into acupuncture. This has shown that acupuncture significantly reduced pain associated with osteoarthritis of the knee, when used as a complement to conventional therapies.

Did you know?

People with high total cholesterol have about two times the risk for heart disease as people with ideal levels.

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

Did you know?

The effects of organophosphate poisoning are referred to by using the abbreviations “SLUD” or “SLUDGE,” It stands for: salivation, lacrimation, urination, defecation, GI upset, and emesis.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library